14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $3.25 $5.20 Thursday, 25th Apr 2024 AVXL stock ended at $3.39. This is 0.587% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 6.62% from a day low at $3.25 to a day high of $3.47.
90 days $3.25 $6.90
52 weeks $3.25 $10.31

Historical Anavex Life Sciences Corp. prices

Date Open High Low Close Volume
Feb 13, 2024 $5.94 $5.95 $5.52 $5.58 1 133 165
Feb 12, 2024 $5.82 $6.15 $5.82 $6.14 923 806
Feb 09, 2024 $5.77 $5.83 $5.65 $5.78 810 298
Feb 08, 2024 $5.66 $5.79 $5.53 $5.69 1 083 294
Feb 07, 2024 $5.94 $6.02 $5.47 $5.59 1 502 502
Feb 06, 2024 $5.31 $5.79 $5.30 $5.79 1 548 283
Feb 05, 2024 $5.69 $5.71 $5.29 $5.36 1 805 499
Feb 02, 2024 $6.04 $6.11 $5.70 $5.73 1 579 478
Feb 01, 2024 $6.00 $6.15 $5.87 $6.15 778 092
Jan 31, 2024 $6.27 $6.36 $5.97 $5.97 1 036 333
Jan 30, 2024 $6.67 $6.67 $6.29 $6.29 993 798
Jan 29, 2024 $6.34 $6.82 $6.25 $6.75 972 119
Jan 26, 2024 $6.73 $6.90 $6.31 $6.33 1 007 733
Jan 25, 2024 $6.58 $6.73 $6.48 $6.64 753 761
Jan 24, 2024 $6.73 $6.83 $6.57 $6.58 824 785
Jan 23, 2024 $6.70 $6.80 $6.47 $6.60 731 296
Jan 22, 2024 $6.09 $6.62 $6.09 $6.60 1 277 301
Jan 19, 2024 $6.01 $6.10 $5.80 $6.05 1 205 825
Jan 18, 2024 $6.10 $6.10 $5.90 $6.01 719 007
Jan 17, 2024 $5.87 $6.07 $5.75 $6.05 787 514
Jan 16, 2024 $5.96 $6.01 $5.79 $5.98 1 272 855
Jan 12, 2024 $6.03 $6.19 $5.92 $5.99 1 358 993
Jan 11, 2024 $6.20 $6.20 $5.95 $6.01 1 538 486
Jan 10, 2024 $6.40 $6.53 $6.19 $6.25 1 130 040
Jan 09, 2024 $6.46 $6.54 $6.34 $6.41 1 084 572
Click to get the best stock tips daily for free!

About Anavex Life Sciences Corp.

Anavex Life Sciences . Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinica... AVXL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT